Related Experiment Video

Updated: May 4, 2026

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis
06:19

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis

Published on: September 9, 2022

4.0K

Pediatric Myalgic Encephalomyelitis/Chronic Fatigue Syndrome

Leonard A Jason1, Kristen Barker, Abigail Brown

  • 1Center for Community Research, DePaul University, Chicago, IL, USA.

Reviews in Health Care
|December 17, 2013
PubMed

Insights

This review examines pediatric Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS), highlighting key differences from adult cases. It aims to improve diagnosis and management of this complex pediatric illness.

Area of Science:

  • Pediatric medicine
  • Immunology
  • Neurology

Background:

  • Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) affects children and adolescents.
  • Significant distinctions exist between pediatric and adult ME/CFS presentations.
  • Current understanding and management of pediatric ME/CFS require further development.

Purpose of the Study:

  • To provide a comprehensive review of pediatric ME/CFS.
  • To highlight key differences between pediatric and adult ME/CFS.
  • To identify challenges in diagnosing and managing pediatric ME/CFS.

Main Methods:

  • Literature review of recent research on pediatric ME/CFS.
  • Analysis of epidemiological data.
  • Examination of diagnostic criteria, treatment strategies, and prognosis.

Main Results:

  • Recent research indicates significant differences between adult and pediatric ME/CFS.
  • Epidemiology, diagnostic criteria, treatment, and prognosis vary in pediatric populations.
  • Challenges in accurate diagnosis and effective management persist.

Conclusions:

  • Pediatric ME/CFS is a distinct entity requiring specialized attention.
  • Further research is crucial to refine diagnostic accuracy.
  • Improved management strategies are needed for better patient outcomes.

Keywords:
DiagnosisMyalgic Encephalomyelitis/Chronic Fatigue SyndromePediatrics

More Related Videos

Author Spotlight: Creating a Versatile Experimental Autoimmune Encephalomyelitis Model Relevant for Both Male and Female Mice05:44

Author Spotlight: Creating a Versatile Experimental Autoimmune Encephalomyelitis Model Relevant for Both Male and Female Mice

Published on: October 13, 2023

2.6K
Myelin Oligodendrocyte Glycoprotein MOG35-55 Induced Experimental Autoimmune Encephalomyelitis EAE in C57BL/6 Mice08:03

Myelin Oligodendrocyte Glycoprotein MOG35-55 Induced Experimental Autoimmune Encephalomyelitis EAE in C57BL/6 Mice

Published on: April 15, 2014

83.9K

Related Concept Videos

Encephalitis l: Introduction01:19

Encephalitis l: Introduction

Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...
15
Myasthenia Gravis ll: Pathophysiology01:22

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
53
Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
3.3K
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
493
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease...
84
Encephalitis ll: Pathophysiology01:26

Encephalitis ll: Pathophysiology

Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
22